RGT-018

N/A

Report date: 2023/07/19 10:21:55
NME

Base Information

Drug NameRGT-018
Drug Alias NameRGT-018
ClassificationSmall molecules
Mechanisms of ActionSon of sevenless homolog 1 inhibitors
TargetsSon of sevenless homolog 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQILU Regor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesQILU Regor Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A